• Mineralys Therapeutics granted inducement stock options covering 14,880 shares to a new non-executive employee on Nov. 3, 2026.
• The employee also received an inducement restricted stock unit award covering 11,160 shares under the 2025 Employment Inducement Incentive Award Plan.
• Both awards have a Nov. 2, 2026, vesting commencement date, with vesting subject to continued service.
• Options vest over four years: 25% on the first anniversary, followed by 1/48th of the total shares each month thereafter.
• Restricted stock units vest over four years, with 25% vesting on each of the first four anniversaries.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611060800PRIMZONEFULLFEED9872015) on November 06, 2026, and is solely responsible for the information contained therein.